References
- CSIR. The Wealth of India, Raw materials. Council of Scientific and Industrial Research, New Delhi 1976; Vol. 10: 581–3
- Asthana R, Raina M K. Pharmacology of Withania somnifera (Linn) Dunal —A review. Indian Drugs 1989; 26: 199–205
- Sharma K, Dandiya P C. Withania somnifera Dunal—present status. Indian Drugs 1992; 29: 247–53
- Subramanian S S, Sethi P D. Withaferin A from Withania coagulans roots. Curr Sci (India) 1969; 38: 267–8
- Kupchan S M, Doskotch R W, Bollinger P, Mc Phail A T, Sim G A, Renauld J AS. The isolation and structural elucidation of a novel steroidal tumor inhibitor from Acnitus arborescens. J Am Chem Soc 1965; 87: 5805–6
- Lavie D, Glotter E, Shvo Y. Constituents of Withania somnifera. J Org Chem 1965; 30: 1774–8
- Shohat B, Gitter S, Abraham A, Lavie D. Antitumor activity of withaferin A. Cancer Chemother Rep 1967; 51: 271–6
- Shohat B, Gitter S, Lavie D. Effect of withaferin A on Ehrlich ascites tumor cells—cytological observations. Int J Cancer 1970; 5: 244–52
- Shohat B, Joshua H. Effect of withaferin A on Ehrlich ascites tumor cell II. Target tumor cell destruction in vivo by immune inactivation. Int J Cancer 1971; 8: 487–96
- Uma Devi P, Sharada A C, Solomon F E, Kamath M S. In vivo growth inhibitory effect of Withania somnifera (Ashwa-gandha) on a transplantable mouse tumor, Sarcoma-180. Indian J Expl Biol 1992; 30: 169–72
- Uma Devi P, Sharada A C, Solomon F E. Antitumor and radiosensitizing effect of the medicinal plant Withania somnifera (Ashwagandha) on a transplantable mouse tumor Sar-coma-180. Indian J Expl Biol 1993; 31: 607–11
- Sharada A C, Solomon F E, Uma Devi P. Toxicity studies on a root extract of Withania somnifera in rats and mice. Int J Pharmacology 1993; 31: 205–12
- Uma Devi P, Sharada A C, Solomon F E, Akagi K, Tanaka Y. Antitumor and radiosensitizing potential of the Indian Medicinal plant Withania somnifera Dunal (Ashwagandha). Sensi-tization News letter (Japan) 1994; 1: 8–11
- Suffness M, Douros J. Drugs of Plant origin. Methods in cancer research, V T De Vita, H Busch. Academic Press, New York 1979; 16: 79–126
- Ghosh M N. Toxicity studies. Fundamentals of experimental pharmacology, 2nd edition, M N Ghosh. Scientific Book Agency, CalculttaIndia 1984; 153–8
- Nias A HW. Radiation biology. Treatment of cancer, K Sikora, K E Hainan. Chapman & Hall Medical, London 1990; 53–75
- Rothman K J. Synergy and antagonism in cause-effect relationships. Am J Epidemology 1974; 99: 385–91
- Sharada A C, Solomon F E, Uma Devi P, Srinivasan K K, Udupa N. Withaferin A and plumbagin: Isolaton and acute toxicity studies. Amala Research Bulletin 1993; 13: 20–3
- Das H, Dutta S K, Bhattacharya B, Chakraborti S K. Antieo-plastic agents from plants antitumor activity of withanolide D. Indian J Cancer Chemother 1985; 7: 59–65
- Palyi I, Tyihak E, Palyi V. Cytological effects of compounds isolated from Withania somnifera Dun. Herba Hung 1969; 8: 73–7
- Chowdhury K, Neogy R K. Mode of action of withaferin A and withanolide D. Biochem Pharmacol 1975; 24: 919–20
- Kupchan S M, Eakim M A, Thomas A M. Tumor inhibitors 69 Structure cytotoxicity relationship among the sesquiterpene lactones. J Med Chem 1971; 14: 1147–52
- Fuska J, Fuskov A, Rosazza J P, Nicholas A W. Novel cyto-toxic and antitumor agents. IV. Withaferin A: relation of its structure to the in vitro cytotoxic effects on P-388 cells. Neoplasma 1984; 31: 31–6
- Maruyama Y, Raju M R. Analysis of cell age distribution during ascites tumor growth (brief communication). J Natl Cancer Inst 1974; 53: 285–7